BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3107804)

  • 81. H-2Ld antigen encoded by a recombinant retrovirus genome is expressed on the surface of infected cells.
    Weis JH; Reiss CS; Mulligan RC; Burakoff SJ; Seidman JG
    Mol Cell Biol; 1985 Jun; 5(6):1379-84. PubMed ID: 2993861
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Inhibition of growth and metastases in mice by immunization with cholesterol hemisuccinate-enriched tumor cells.
    Skornick Y; Gorelik E; Klausner J; Shinitzky M; Sindelar WF
    Cancer Lett; 1984 Dec; 25(2):153-61. PubMed ID: 6509434
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Immuno-selection in vivo of H-2D phenotypic variants from a metastatic clone of sarcoma cells results in cell lines of altered metastatic competence.
    Katzav S; Segal S; Feldman M
    Int J Cancer; 1984 Mar; 33(3):407-15. PubMed ID: 6698640
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Alteration of the tumorigenic and metastatic properties of neoplastic cells is associated with the process of calcium phosphate-mediated DNA transfection.
    Kerbel RS; Waghorne C; Man MS; Elliott B; Breitman ML
    Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1263-7. PubMed ID: 3469668
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Tumor dependency of concanavalin A-induced potentiation of tumor cell immunogenicity.
    Kataoka T; Oh-hashi F; Akabori Y; Sakurai Y; Okabe M; Gomi K
    Gan; 1983 Jun; 74(3):412-8. PubMed ID: 6411514
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Proceedings: in vitro destruction of 3LL tumor cells by syngeneic in vitro-sensitized lymphocytes.
    Schechter B; Treves AJ; Feldman M
    Isr J Med Sci; 1975 Dec; 11(12):1396-7. PubMed ID: 1218994
    [No Abstract]   [Full Text] [Related]  

  • 87. Binding of anti-tumor immunoglobulins and their daunomycin conjugates to the tumor and its metastase. In vitro and in vivo studies with Lewis lung carcinoma.
    Hurwitz E; Schechter B; Arnon R; Sela M
    Int J Cancer; 1979 Oct; 24(4):461-70. PubMed ID: 393637
    [TBL] [Abstract][Full Text] [Related]  

  • 88. MHC imbalance and metastatic spread in Lewis lung carcinoma clones.
    Eisenbach L; Segal S; Feldman M
    Int J Cancer; 1983 Jul; 32(1):113-20. PubMed ID: 6862690
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The influence of major histocompatibility complex class I antigens on tumor growth and metastasis.
    Hämmerling GJ; Klar D; Pülm W; Momburg F; Moldenhauer G
    Biochim Biophys Acta; 1987 Nov; 907(3):245-59. PubMed ID: 3314998
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Clonal variation in cell surface display of an H-2 protein lacking a cytoplasmic tail.
    Zuniga MC; Hood LE
    J Cell Biol; 1986 Jan; 102(1):1-10. PubMed ID: 3941149
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Modulation by IFN-gamma of the metastatic ability of murine, human, and H-2-transfected tumor cells.
    Lollini PL; De Giovanni C; Nicoletti G; Scotlandi K; Landuzzi L; Nanni P
    Tumori; 1989 Aug; 75(4):383-8. PubMed ID: 2510384
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Tumor cell variants obtained by mutagenesis of a Lewis lung carcinoma cell line: immune rejection by syngeneic mice.
    Van Pel A; Georlette M; Boon T
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5282-5. PubMed ID: 291945
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Tumorigenicity of mouse T lymphoma cells is controlled by the level of major histocompatibility complex class I H-2Kk antigens.
    VandenDriessche T; Bakkus M; Toussaint-Demylle D; Thielemans K; Verschueren H; De Baetselier P
    Clin Exp Metastasis; 1994 Jan; 12(1):73-83. PubMed ID: 8287623
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Role of macrophages in the host response to Lewis lung peritoneal carcinomatosis.
    Barth MW; Morahan PS
    Cancer Immunol Immunother; 1994 Apr; 38(4):233-42. PubMed ID: 8168118
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Inhibition of Lewis lung tumor growth and metastasis by Ehrlich ascites tumor growing in the same host.
    Himmele JC; Rabenhorst B; Werner D
    J Cancer Res Clin Oncol; 1986; 111(2):160-5. PubMed ID: 3700461
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Mice coisogenically immunized against H-2 class I antigens on transfected L cells reject transplanted embryonal carcinoma cells.
    Moser AR; Johnson LL; Dove WF
    Immunogenetics; 1985; 22(6):533-41. PubMed ID: 4077147
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Modulation of the tumorigenicity of human adenovirus-12-transformed cells by interferon.
    Hayashi H; Tanaka K; Jay F; Khoury G; Jay G
    Cell; 1985 Nov; 43(1):263-7. PubMed ID: 4075396
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Resistance and susceptibility to pulmonary metastasis of Lewis lung carcinoma in different mouse strains.
    Hergueux J; Bischoff P; Donner M
    Exp Cell Biol; 1983; 51(4):181-91. PubMed ID: 6873435
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Modification of mouse immune responses against allogeneic tumor by pretreatment of antigen with mitomycin C or X-irradiation.
    Hoffmann CC; Ehrke MJ; Papp G; Mihich E
    J Immunopharmacol; 1980; 2(2):213-23. PubMed ID: 6821578
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Expression of complete transplantation antigens by mammalian cells transformed with truncated class I genes.
    Goodenow RS; Stroynowski I; McMillan M; Nicolson M; Eakle K; Sher BT; Davidson N; Hood L
    Nature; 1983 Feb; 301(5899):388-94. PubMed ID: 6823314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.